Insulet (Nasdaq:PODD) today revealed plans for its innovation pipeline, which includes the next-generation Omnipod 6 system.

Insulet Corporation (NASDAQ: PODD) ("Insulet" or the "Company"), the global leader in tubeless insulin pump technology with ...

Q3 2025 Management View CEO Ashley McEvoy welcomed Flavia Pease as the new CFO and announced Eric Benjamin's promotion to COO and the appointment of Manoj Raghunandanan as Chief Growth Officer. McEvoy ...

Medical device maker Insulet on Thursday posted third-quarter results that surpassed Wall Street's expectations on strong demand for its wearable insulin pumps, which eliminate the need for daily ...

Medical devices are not particularly known for bold branding. Omnipod, an insulin pump owned by Insulet, aims to change that with its own custom color created with Pantone. Last week, the 25-year-old ...

ACTON, Mass. - Insulet Corporation (NASDAQ:PODD), a $22.7 billion medical device company with impressive 26% year-over-year revenue growth, has partnered with Pantone to create "Omnipod Mango," a new ...

Insulet is bringing a splash of color to the diabetes technology market. Working with Pantone, the insulin pump company has created the “bright and joyful tropical orange yellow” color Omnipod Mango.

In an age where colours are increasingly disappearing from commercial brands, Insulet is looking to buck the trend – creating a tropical hue via its Omnipod insulin pump portfolio. The diabetes giant ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, and Pantone ®, the global authority on color ...

Q2 revenue rises 32.9% Y/Y to $649.1 million, beating estimates and topping guidance range. Insulet raises FY25 sales outlook to $2.57 billion–$2.63 billion, above prior view of $2.47 billion–$2.53 ...